EUCTR2005-005481-36-PT进行中（未招募）不适用
Alfuzosin in Uretheric Stones - ALF-STONE
Sanofi-Synthelabo Produtos Farmaceuticos, S.A.0 个研究点目标入组 220 人开始时间: 2006年3月14日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 18 or more
- •Patients with imagiologic evidence of uretheric stones
- •Informed signed consent to participate in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Women pregnant or breast feeding
- •Patients with renal impairment (creatinine > 2mg/dl)
研究者
相似试验
终止
3 期
ALF-STONE: Alfuzosin in Uretheric StonesProstatic HyperplasiaNCT00454402Sanofi220
撤回
3 期
Use of Alfuzosin in Stone Treatment With ESWLUrinary CalculiNCT00388271Singapore General Hospital
已完成
3 期
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral CalculiKidney CalculiColicUreteral CalculiNCT00177086University of Minnesota76
已完成
3 期
Alfuzosin Hydrochloride to Relieve Ureteral Stent DiscomfortUreteral Stent DiscomfortNCT00467467University of Minnesota60
Unknown
不适用
Intraureteral Lidocaine for Post-Ureteroscopy PainRenal CalculiUreteral CalculiNCT01450566Queen's University48